SciBase

SciBase is a global medical technology company headquartered in Stockholm, Sweden, that has developed a unique point-of-care platform for the non-invasive detection of skin cancer and other skin conditions. A pioneer in the field of augmented intelligence, SciBase combines artificial intelligence with Electrical Impedance Spectroscopy (EIS) to provide objective information to assist dermatologists and others in clinical decision-making. SciBase’s products include Nevisense and Nevisense-Go, and to date, the platform has been dedicated to the fields of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. Nevisense is the only FDA-approved device in the United States for melanoma detection and the only MDR-approved skin cancer detection technology in Europe.